Fibrinogen reconstitution after therapeutic apheresis: Comparison of double‐filtration plasmapheresis, plasma exchange, and immunoadsorption
- 30 March 2021
- journal article
- research article
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 36 (4) , 574-583
Abstract
Background: Fibrinogen reconstitution after therapeutic apheresis has been poorly studied. Apheresis modalities, for example, plasma exchange (PE), double‐filtration plasmapheresis (DFPP), or selective immunoadsorption (IA), may have different impacts.Methods: We retrospectively investigated therapeutic apheresis sessions performed at our center across four modalities (PE, DFPP, and IA with or without plasma filtration). Fibrinogen levels were assessed at the beginning and end of each apheresis session, and immediately before the subsequent session. We adjusted measurements on hematocrit values to account for hemoconcentration.Results: Between January 10, 2016 and March 2, 2020, we included 90 patients for a total of 754 apheresis sessions (PE: 35; DFPP: 351; IA only: 109; IA + plasma filtration: 259). Each patient received a median of five sessions (1Q 3; 3Q 9); median plasma volume treated was 5.5 L (1Q 4.3 L; 3Q 7.0 L). Within a session, DFPP and PE induced a significantly greater depletion of fibrinogen than both IA modalities, even after adjustment for the treated plasma volume. Median fibrinogen reconstitution was 0.8 (0.4‐1.2) g/L (median time between sessions: 38 hours). In multivariate analysis, fibrinogen reconstitution was significantly associated with intersession time (+0.66 g/L/log‐hour P < .001), apheresis modality (ANOVA; P < .001), initial fibrinogen concentration (+0.15 g/L per gram of fibrinogen; P < .001), and the last fibrinogen concentration from the previous apheresis session (−0.14 g/L per gram of fibrinogen; P < .001). In a model that considered hemoconcentration, the results were unchanged.Conclusions: We demonstrate that fibrinogen reconstitution was highly variable between patients and apheresis sessions. Apheresis modalities had a significant impact on fibrinogen reconstitution, regardless of hemoconcentration.Keywords
This publication has 21 references indexed in Scilit:
- ABO antibody and complement depletion by immunoadsorption combined with membrane filtration--a randomized, controlled, cross-over trialNephrology Dialysis Transplantation, 2013
- Fibrinogen concentrate reduces intraoperative bleeding when used as first-line hemostatic therapy during major aortic replacement surgery: Results from a randomized, placebo-controlled trialThe Journal of Thoracic and Cardiovascular Surgery, 2013
- Therapeutic Potential of Low‐Density Lipoprotein Apheresis in the Management of Peripheral Artery Disease in Patients With Chronic Kidney DiseaseTherapeutic Apheresis and Dialysis, 2012
- A Critical Review on the Use of Lipid Apheresis and Rheopheresis for Treatment of Peripheral Arterial Disease and the Diabetic Foot SyndromeSeminars in Dialysis, 2011
- Lipid apheresis and rheopheresis for treatment of peripheral arterial diseaseAtherosclerosis Supplements, 2009
- The Effects of Fibrinogen Levels on Thromboelastometric Variables in the Presence of ThrombocytopeniaAnesthesia & Analgesia, 2009
- Selective Fibrinogen Apheresis for Improvement in Microvascular HemodynamicsBlood Purification, 2007
- Rheopheresis: Rheologic, Functional, and Structural AspectsTherapeutic Apheresis, 2000
- Clotting factor levels and the risk of diffuse microvascular bleeding in the massively transfused patientBritish Journal of Haematology, 1987
- Studies of the Metabolism and Distribution of Fibrinogen in Patients with Hemophilia A*Journal of Clinical Investigation, 1967